EBV-Related Lymphoma — Trials

EBV-Related Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04664179	EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma(CILESTE)	recruiting	Phase 1	52	Baylor College of MedicineOTHER	1	Jun 25, 2026	clinicaltrials
NCT07097363	Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma	recruiting	Phase 2	18	University of WashingtonOTHER	1	Apr 23, 2026